IL226955A - Methods for identifying a b-cell clone that specifically binds to an antigen of interest, methods for producing an immunobinder and immunobinders produced by said methods - Google Patents

Methods for identifying a b-cell clone that specifically binds to an antigen of interest, methods for producing an immunobinder and immunobinders produced by said methods

Info

Publication number
IL226955A
IL226955A IL226955A IL22695513A IL226955A IL 226955 A IL226955 A IL 226955A IL 226955 A IL226955 A IL 226955A IL 22695513 A IL22695513 A IL 22695513A IL 226955 A IL226955 A IL 226955A
Authority
IL
Israel
Prior art keywords
methods
immunobinders
immunobinder
antigen
interest
Prior art date
Application number
IL226955A
Other languages
Hebrew (he)
Other versions
IL226955A0 (en
Original Assignee
Esbatech Alcon Biomed Res Unit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CH2009/000222 external-priority patent/WO2009155726A2/en
Priority claimed from PCT/CH2010/000044 external-priority patent/WO2010096941A1/en
Application filed by Esbatech Alcon Biomed Res Unit filed Critical Esbatech Alcon Biomed Res Unit
Publication of IL226955A0 publication Critical patent/IL226955A0/en
Publication of IL226955A publication Critical patent/IL226955A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/5052—Cells of the immune system involving B-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL226955A 2009-02-24 2013-06-13 Methods for identifying a b-cell clone that specifically binds to an antigen of interest, methods for producing an immunobinder and immunobinders produced by said methods IL226955A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15510509P 2009-02-24 2009-02-24
US15504109P 2009-02-24 2009-02-24
CH8322009 2009-06-02
PCT/CH2009/000222 WO2009155726A2 (en) 2008-06-25 2009-06-25 Humanization of rabbit antibodies using a universal antibody framework
PCT/CH2010/000044 WO2010096941A1 (en) 2009-02-24 2010-02-22 Methods for identifying immunobinders of cell-surface antigens

Publications (2)

Publication Number Publication Date
IL226955A0 IL226955A0 (en) 2013-07-31
IL226955A true IL226955A (en) 2015-04-30

Family

ID=48917567

Family Applications (4)

Application Number Title Priority Date Filing Date
IL226955A IL226955A (en) 2009-02-24 2013-06-13 Methods for identifying a b-cell clone that specifically binds to an antigen of interest, methods for producing an immunobinder and immunobinders produced by said methods
IL226956A IL226956A (en) 2009-02-24 2013-06-13 Methods for identifying an immunobinder that specifically binds to an antigen of interest
IL237985A IL237985B (en) 2009-02-24 2015-03-26 Humanized immunobinder capable of binding to an antigen of interest
IL26315818A IL263158B (en) 2009-02-24 2018-11-20 Methods for identifying immunobinders of cell-surface antigens

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL226956A IL226956A (en) 2009-02-24 2013-06-13 Methods for identifying an immunobinder that specifically binds to an antigen of interest
IL237985A IL237985B (en) 2009-02-24 2015-03-26 Humanized immunobinder capable of binding to an antigen of interest
IL26315818A IL263158B (en) 2009-02-24 2018-11-20 Methods for identifying immunobinders of cell-surface antigens

Country Status (12)

Country Link
JP (3) JP6161655B2 (en)
KR (4) KR101817279B1 (en)
CN (1) CN105116138A (en)
BR (1) BRPI1005398A2 (en)
CL (1) CL2011001453A1 (en)
ES (1) ES2618181T3 (en)
IL (4) IL226955A (en)
MX (1) MX352922B (en)
PH (1) PH12014502468B1 (en)
RU (2) RU2577965C2 (en)
SG (3) SG10201708233VA (en)
ZA (1) ZA201103125B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110016462B (en) * 2019-02-20 2020-04-24 优睿赛思(武汉)生物科技有限公司 Method for efficiently separating single antigen-specific B lymphocytes from spleen cells

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63253098A (en) * 1987-04-10 1988-10-20 Ube Ind Ltd Monoclonal antibody against human antibody, its production and use thereof
IL91948A (en) 1988-10-26 1994-05-30 Immunomedics Removal of immunoreactive components from a sample
US5417972A (en) * 1993-08-02 1995-05-23 The Board Of Trustees Of The Leland Stanford Junior University Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM
KR0119909B1 (en) * 1993-10-05 1997-10-20 김은영 Immunology measurement using flow cytometer
EP1709970A1 (en) * 1995-04-27 2006-10-11 Abgenix, Inc. Human antibodies against EGFR, derived from immunized xenomice
ATE253593T1 (en) * 1996-07-16 2003-11-15 Plueckthun Andreas Prof Dr IMMUNOGLOBULIN SUPERFAMILY DOMAINS AND FRAGMENTS WITH INCREASED SOLUBILITY
DK1506236T3 (en) * 2002-05-22 2013-03-04 Esbatech A Novartis Co Llc IMMUNGLOBULIN FRAMEWORKS PROVIDING IMPROVED STABILITY IN THE INTRACELLULAR ENVIRONMENT AND PROCEDURES FOR IDENTIFICATION THEREOF
CN1396182A (en) * 2002-07-31 2003-02-12 陕西超英生物医学研究开发有限公司 Human monoclonal antibody of human endophloeodal growth factor receptor 2 protein and its preparing process
AU2003264009A1 (en) 2002-08-15 2004-03-03 Epitomics, Inc. Humanized rabbit antibodies
CA2505924A1 (en) * 2002-11-13 2004-05-27 Micromet Ag Method for identifying antigen specific b cells
JP4336812B2 (en) * 2003-03-07 2009-09-30 博夫 岩田 Analytical method for rapid identification of surface antigens expressed in cells
US20070087331A1 (en) * 2003-05-15 2007-04-19 Cytos Biotechnology Ag Selection of b cells with specificity if interest: method of preparation and use
CN100415765C (en) 2003-08-07 2008-09-03 宜康公司 Methods for humanizing rabbit monoclonal antibodies
CA2655511C (en) * 2005-07-01 2017-03-21 John Schrader Methods of isolating cells and generating monoclonal antibodies
US20070134249A1 (en) 2005-12-08 2007-06-14 Genitope Corporation Combination therapy and antibody panels
KR101363695B1 (en) * 2005-12-28 2014-02-14 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 An antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved
MY159787A (en) * 2006-06-02 2017-01-31 Regeneron Pharma High affinity antibodies to human il-6 receptor
WO2008004834A1 (en) * 2006-07-06 2008-01-10 Isu Abxis Co., Ltd Humanized monoclonal antibody highly binding to epidermal growth factor receptor, egf receptor

Also Published As

Publication number Publication date
MX352922B (en) 2017-12-14
KR20190020202A (en) 2019-02-27
ZA201103125B (en) 2012-08-29
RU2011124039A (en) 2012-12-20
KR20180005752A (en) 2018-01-16
PH12014502468A1 (en) 2016-01-18
ES2618181T3 (en) 2017-06-21
RU2017135831A3 (en) 2019-04-09
IL263158A (en) 2018-12-31
IL237985B (en) 2018-12-31
CN105116138A (en) 2015-12-02
PH12014502468B1 (en) 2016-01-18
RU2017135831A (en) 2019-04-09
KR20160022397A (en) 2016-02-29
JP6604989B2 (en) 2019-11-13
JP6161655B2 (en) 2017-07-12
CL2011001453A1 (en) 2012-02-24
IL226956A (en) 2015-04-30
RU2577965C2 (en) 2016-03-20
SG2014014864A (en) 2014-09-26
KR101817279B1 (en) 2018-01-10
IL226955A0 (en) 2013-07-31
IL263158B (en) 2019-10-31
KR20160150642A (en) 2016-12-30
JP2015146825A (en) 2015-08-20
BRPI1005398A2 (en) 2019-03-26
KR102059866B1 (en) 2019-12-27
JP2017192384A (en) 2017-10-26
SG10201408247SA (en) 2015-02-27
JP2018196395A (en) 2018-12-13
IL226956A0 (en) 2013-07-31
SG10201708233VA (en) 2017-11-29
KR101689791B1 (en) 2016-12-26

Similar Documents

Publication Publication Date Title
IL249501A0 (en) Process for obtaining antibodies
IL228559A0 (en) Preparation of maytansinoid antibody conjugates by a one step process
EP2507381A4 (en) Multispecific antibodies, antibody analogs, compositions, and methods
SI2400298T1 (en) Single B-cell cultivation method and specific antibody production
IL214884A0 (en) Trivalent, bispecific antibodies
IL223018A0 (en) Method for preparing antibodies having improved properties
IL220404A (en) Humanized antibodies
EP2646879A4 (en) Method of producing toner
EP2540745A4 (en) Fully humanized anti-her2 antibody, preparation method and use thereof
IL200919A0 (en) Methods for generation of antibodies
PT2646466T (en) Means and methods for producing high affinity antibodies
EP2659270A4 (en) Comprehensive monoclonal antibody generation
HK1188182A1 (en) Method for producing ornament
EP2617503A4 (en) Method for producing ferrous powder
EP2551547A4 (en) Method for producing spring
EP2542262A4 (en) Monoclonal antibodies directed to cd20
EP2543658A4 (en) Method for producing a-acyloxycarbonyl compound and novel a-acyloxycarbonyl compound
IL226955A (en) Methods for identifying a b-cell clone that specifically binds to an antigen of interest, methods for producing an immunobinder and immunobinders produced by said methods
EP2573159A4 (en) Method for producing powder mixture
EP2313777A4 (en) A method of characterizing antibodies
EP2641967A4 (en) Method for producing b-cell capable of producing human-type antibody
EP2444484A4 (en) Method for producing antibodies using cancer cells
EP2772544A4 (en) Novel compound and method for producing same
EP2695938A4 (en) Antibody production method
HK1199613A1 (en) Method for producing analytical aids

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed